Pursuant to the relevant provisions of the SEBI Listing Regulations, Supriya Lifescience has informed that the officials of the Company, will be interacting with Analysts/Investors on April 1, 2022 via video conference. The copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.
